Order Article Reprints

Resch MD, Wen K, Mazboudi R, Mulhall Maasz H, Persaud M, Garvey K, Gallardo L, Gottlieb P, Alimova A, Khayat R, et al. Immunogenicity and Efficacy of Monovalent and Bivalent Formulations of a Virus-Like Particle Vaccine against SARS-CoV-2. Vaccines. 2022; 10(12):1997. https://doi.org/10.3390/vaccines10121997

Resch, Matthew D., Ke Wen, Ryan Mazboudi, Hannah Mulhall Maasz, Mirjana Persaud, Kaitlyn Garvey, Leslie Gallardo, Paul Gottlieb, Aleksandra Alimova, Reza Khayat, and et al. 2022. "Immunogenicity and Efficacy of Monovalent and Bivalent Formulations of a Virus-Like Particle Vaccine against SARS-CoV-2" Vaccines 10, no. 12: 1997. https://doi.org/10.3390/vaccines10121997

Resch, M. D., Wen, K., Mazboudi, R., Mulhall Maasz, H., Persaud, M., Garvey, K., Gallardo, L., Gottlieb, P., Alimova, A., Khayat, R., Morales, J., Bielefeldt-Ohmann, H., Bowen, R. A., & Galarza, J. M. (2022). Immunogenicity and Efficacy of Monovalent and Bivalent Formulations of a Virus-Like Particle Vaccine against SARS-CoV-2. Vaccines, 10(12), 1997. https://doi.org/10.3390/vaccines10121997